134 related articles for article (PubMed ID: 20542784)
1. A European multicentre, randomised study of the MAR-Tyn cobalt chromium tin-coated stent in patients with de novo coronary artery lesions: study design and protocol.
Kastrati A; Balducelli M; Di Sciascio G; Moccetti T; Bortone AS; Colombo A; Waltenberger J; Hehrlein C;
EuroIntervention; 2010 Apr; 5(8):976-80. PubMed ID: 20542784
[TBL] [Abstract][Full Text] [Related]
2. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-human randomised trial, balloon first vs. stent first.
Gutiérrez-Chico JL; van Geuns RJ; Koch KT; Koolen JJ; Duckers H; Regar E; Serruys PW
EuroIntervention; 2011 Oct; 7(6):711-22. PubMed ID: 21986329
[TBL] [Abstract][Full Text] [Related]
4. Outcome of patients treated by a novel thin-strut cobalt-chromium stent in the drug-eluting stent era: Results of the SKICE (Skylor in real world practice) registry.
Burzotta F; Trani C; Todaro D; Mazzari MA; Porto I; De Vita M; Brugaletta S; Coroleu SF; Niccoli G; Leone AM; Giammarinaro M; Mongiardo R; Schiavoni G; Crea F
Catheter Cardiovasc Interv; 2009 Mar; 73(4):457-65. PubMed ID: 19229977
[TBL] [Abstract][Full Text] [Related]
5. 5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trial.
Stone GW; Goldberg S; O'Shaughnessy C; Midei M; Siegel RM; Cristea E; Dangas G; Lansky AJ; Mehran R
JACC Cardiovasc Interv; 2011 Mar; 4(3):300-9. PubMed ID: 21435608
[TBL] [Abstract][Full Text] [Related]
6. Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent).
Ellis SG; Stone GW; Cox DA; Hermiller J; O'Shaughnessy C; Mann T; Turco M; Caputo R; Bergin PJ; Bowman TS; Baim DS;
JACC Cardiovasc Interv; 2009 Dec; 2(12):1248-59. PubMed ID: 20129552
[TBL] [Abstract][Full Text] [Related]
7. Randomised comparison of titanium-nitride-oxide coated stents with bare metal stents: five year follow-up of the TiNOX trial.
Moschovitis A; Simon R; Seidenstücker A; Klauss V; Baylacher M; Lüscher TF; Moccetti T; Windecker S; Meier B; Hess OM
EuroIntervention; 2010 May; 6(1):63-8. PubMed ID: 20542799
[TBL] [Abstract][Full Text] [Related]
8. French Ministry of Health prospective multicentre study using bio-active stents coated with titanium nitride oxide: the EVIDENCE registry.
Angioi M; Barragan P; Cattan S; Collet F; Dupouy P; Durand P; Fajadet J; Finet G; Gerardin B; Gommeaux A; Karsenty B; Loubeyre C; Meyer P; Morice MC; Moulichon MÉ; Sayah S; Silvestri M; Tabone X; Unterseeh T; Wittenberg O; Lablanche JM
Arch Cardiovasc Dis; 2012 Feb; 105(2):60-7. PubMed ID: 22424323
[TBL] [Abstract][Full Text] [Related]
9. Early and mid-term clinical outcomes with the CATANIA coronary stent system vs. bare metal stents in patients with coronary artery disease.
Capodanno D; La Manna A; Di Salvo ME; Sanfilippo A; Corcos T; Tamburino C
Cardiovasc Revasc Med; 2009; 10(4):216-20. PubMed ID: 19815167
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries.
Wöhrle J; Werner GS
Catheter Cardiovasc Interv; 2013 Apr; 81(5):793-9. PubMed ID: 22511572
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome of titanium-nitride-oxide-coated cobalt-chromium stents in patients with de novo coronary lesions: 12-month results of the OPTIMAX first-in-man study.
Karjalainen PP; Mikkelsson J; Paana T; Nammas W
Catheter Cardiovasc Interv; 2016 Mar; 87(4):E122-7. PubMed ID: 26308878
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes.
Han Y; Jing Q; Xu B; Yang L; Liu H; Shang X; Jiang T; Li Z; Zhang H; Li H; Qiu J; Liu Y; Li Y; Chen X; Gao R;
JACC Cardiovasc Interv; 2009 Apr; 2(4):303-9. PubMed ID: 19463441
[TBL] [Abstract][Full Text] [Related]
13. Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study.
Beijk MA; Klomp M; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; Tijssen JG; Piek JJ; de Winter RJ
Catheter Cardiovasc Interv; 2011 Aug; 78(2):189-95. PubMed ID: 21542109
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study.
Unverdorben M; Vallbracht C; Cremers B; Heuer H; Hengstenberg C; Maikowski C; Werner GS; Antoni D; Kleber FX; Bocksch W; Leschke M; Ackermann H; Boxberger M; Speck U; Degenhardt R; Scheller B
EuroIntervention; 2015 Dec; 11(8):926-34. PubMed ID: 25169589
[TBL] [Abstract][Full Text] [Related]
15. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial.
Holmes DR; Teirstein PS; Satler L; Sketch MH; Popma JJ; Mauri L; Wang HP; Schleckser PA; Cohen SA;
JACC Cardiovasc Interv; 2008 Aug; 1(4):439-48. PubMed ID: 19463342
[TBL] [Abstract][Full Text] [Related]
16. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
17. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
[TBL] [Abstract][Full Text] [Related]
18. 3-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT II trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions).
Garg S; Serruys P; Onuma Y; Dorange C; Veldhof S; Miquel-Hébert K; Sudhir K; Boland J; Huber K; Garcia E; te Riele JA;
JACC Cardiovasc Interv; 2009 Dec; 2(12):1190-8. PubMed ID: 20129545
[TBL] [Abstract][Full Text] [Related]
19. Thin strut chrome-cobalt stent implantation for treatment of de-novo lesions in small coronary vessels: results of the RISICO Italian Registry (Registro Italiano Mini VISION nei piccolo Vasi) utilizing the Mini VISION coronary stent platform.
Brambilla N; Morici N; Bedogni F; De Benedictis M; Scrocca I; Naldi M; Fiscella A; Prosperi F; Dominici M; Rebuzzi A; Colombo A; Sangiorgi GM;
J Cardiovasc Med (Hagerstown); 2009 Nov; 10(11):852-8. PubMed ID: 19550353
[TBL] [Abstract][Full Text] [Related]
20. Clinical investigation into the observation that silicon carbide coating on cobalt chromium stents leads to early differentiating functional endothelial layer, increased safety and DES-like recurrent stenosis rates: results of the PRO-Heal Registry (PRO-Kinetic enhancing rapid in-stent endothelialisation).
Dahm JB; Willems T; Wolpers HG; Nordbeck H; Becker J; Ruppert J
EuroIntervention; 2009 Jan; 4(4):502-8. PubMed ID: 19284073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
